Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Möller

Showing results (41-50 of 319) with videos related to

Pageof 32
Sort By:
Leukemia|November 14, 2019
Physiological levels of the PTEN-PI3K-AKT axis activity are required for maintenance of Burkitt lymphomaFranziska Gehringer, Stephanie Ellen Weissinger, Peter Möller, et al.
Journal of Pediatric Hematology/Oncology|May 14, 2010
Endolymphatic non-langerhans cell histiocytosis of the larynx: report of an uncommon disease manifestationCarl Friedrich Classen, Dieter Haffner, Horst Nizze, et al.
Nucleic Acids Research|October 13, 2004
Identification of novel Myc target genes with a potential role in lymphomagenesisDragan Marinkovic, Tatjana Marinkovic, Eniko Kokai, et al.
International Journal of Cancer|December 17, 2009
Expression and prognostic significance of APAF-1, caspase-8 and caspase-9 in stage II/III colon carcinoma: caspase-8 and caspase-9 is associated with poor prognosisJörn Sträter, Ines Herter, Gaby Merkel, et al.
Neoplasia (New York, N.Y.)|June 8, 2021
Spatial distribution of immune checkpoint proteins in histological subtypes of lung adenocarcinomaSarah Müller, Stefanie Mayer, Peter Möller, et al.
Neoplasia (New York, N.Y.)|February 4, 2024
Molecular heterogeneity in histomorphologic subtypes of lung adeno carcinoma represents a challenge for treatment decisionTobias Kolb, Sarah Müller, Peter Möller, et al.
Critical Care (London, England)|September 29, 2012
Erythropoietin in the critically ill: do we ask the right questions?Oscar McCook, Michael Georgieff, Angelika Scheuerle, et al.
Hemasphere|March 4, 2024
CDK6 protein expression is associated with disease progression and treatment resistance in multiple myelomaJohannes Steinhart, Peter Möller, Miriam Kull, et al.
British Journal of Haematology|June 16, 2016
Silencer of Cytokine Signaling 1 gene is not hypermethylated in diffuse large B-cell lymphomaJochen K Lennerz, Stephanie E Weissinger, Uwe Gerstenmaier, et al.
International Journal of Cancer|April 22, 2003
Two novel in vitro human hepatoblastoma models, HepU1 and HepU2, are highly characteristic of fetal-embryonal differentiation in hepatoblastomaStefanie Scheil, Silvia Hagen, Silke Brüderlein, et al.
Pageof 32

Showing results (41-50 of 319) with videos related to

Sort By:
Pageof 32
Leukemia|November 14, 2019
Physiological levels of the PTEN-PI3K-AKT axis activity are required for maintenance of Burkitt lymphomaFranziska Gehringer, Stephanie Ellen Weissinger, Peter Möller, et al.
Journal of Pediatric Hematology/Oncology|May 14, 2010
Endolymphatic non-langerhans cell histiocytosis of the larynx: report of an uncommon disease manifestationCarl Friedrich Classen, Dieter Haffner, Horst Nizze, et al.
Nucleic Acids Research|October 13, 2004
Identification of novel Myc target genes with a potential role in lymphomagenesisDragan Marinkovic, Tatjana Marinkovic, Eniko Kokai, et al.
International Journal of Cancer|December 17, 2009
Expression and prognostic significance of APAF-1, caspase-8 and caspase-9 in stage II/III colon carcinoma: caspase-8 and caspase-9 is associated with poor prognosisJörn Sträter, Ines Herter, Gaby Merkel, et al.
Neoplasia (New York, N.Y.)|June 8, 2021
Spatial distribution of immune checkpoint proteins in histological subtypes of lung adenocarcinomaSarah Müller, Stefanie Mayer, Peter Möller, et al.
Neoplasia (New York, N.Y.)|February 4, 2024
Molecular heterogeneity in histomorphologic subtypes of lung adeno carcinoma represents a challenge for treatment decisionTobias Kolb, Sarah Müller, Peter Möller, et al.
Critical Care (London, England)|September 29, 2012
Erythropoietin in the critically ill: do we ask the right questions?Oscar McCook, Michael Georgieff, Angelika Scheuerle, et al.
Hemasphere|March 4, 2024
CDK6 protein expression is associated with disease progression and treatment resistance in multiple myelomaJohannes Steinhart, Peter Möller, Miriam Kull, et al.
British Journal of Haematology|June 16, 2016
Silencer of Cytokine Signaling 1 gene is not hypermethylated in diffuse large B-cell lymphomaJochen K Lennerz, Stephanie E Weissinger, Uwe Gerstenmaier, et al.
International Journal of Cancer|April 22, 2003
Two novel in vitro human hepatoblastoma models, HepU1 and HepU2, are highly characteristic of fetal-embryonal differentiation in hepatoblastomaStefanie Scheil, Silvia Hagen, Silke Brüderlein, et al.
Pageof 32